Diagnosis of salivary gland tumors: Does the triple diagnosis method have value?

Abstract

AbstractBackgroundAppropriate clinical management of salivary gland lesions requires a determination as to whether a salivary gland nodule is benign or malignant. Approximately three‐quarters of all salivary gland nodules represent benign neoplasms. Separation of salivary gland carcinomas from benign lesions can be diagnostically challenging. The Milan System for Reporting Salivary Gland Cytopathology recommends the correlation of cytologic diagnoses with imaging and clinical findings creating a diagnostic triplet. How often the “Triple Diagnosis” method is used and its accuracy in separating salivary gland nodules into benign and malignant groups are unknown.MethodsAn electronic records search of cytology files at the University of Missouri was performed for fine needle aspirates of the salivary gland obtained between September 2018 and August 2022. Chart review was performed for preoperative clinical and imaging diagnoses. Diagnostic “Triplets” constructed from cytologic, clinical, and imaging diagnoses were correlated with final surgical pathology diagnosis.ResultsOne hundred and thirty‐six FNAs were identified. Eighty‐seven cases had preoperative imaging with 52 of these cases having clinical diagnoses. Due to the lack of a definitive clinical or imaging diagnosis for a nodule as benign or malignant, only 12 (23%) cases had definitive “Triplets.” Nine (17%) “Triplets” were benign and three (6%) were malignant. Accuracy of concordant triplets was 100% for the prediction of malignancy and 89% for the prediction of a benign result as determined by final histologic diagnoses.ConclusionWhile highly accurate in predicting the benign or malignant nature of a salivary gland nodule, concordant triplets made up only 23% of cases limiting their clinical utility.